121 related articles for article (PubMed ID: 20495358)
1. Androgen receptor responsive enhancers are flanked by consistently-positioned H3-acetylated nucleosomes.
Berman BP; Frenkel B; Coetzee GA; Jia L
Cell Cycle; 2010 Jun; 9(11):2249-50. PubMed ID: 20495358
[No Abstract] [Full Text] [Related]
2. Dynamic nucleosome-depleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells.
Andreu-Vieyra C; Lai J; Berman BP; Frenkel B; Jia L; Jones PA; Coetzee GA
Mol Cell Biol; 2011 Dec; 31(23):4648-62. PubMed ID: 21969603
[TBL] [Abstract][Full Text] [Related]
3. Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor.
Kang Z; Jänne OA; Palvimo JJ
Mol Endocrinol; 2004 Nov; 18(11):2633-48. PubMed ID: 15308689
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of HER-2/neu kinase impairs androgen receptor recruitment to the androgen responsive enhancer.
Liu Y; Majumder S; McCall W; Sartor CI; Mohler JL; Gregory CW; Earp HS; Whang YE
Cancer Res; 2005 Apr; 65(8):3404-9. PubMed ID: 15833875
[TBL] [Abstract][Full Text] [Related]
5. Acetylated histone variant H2A.Z is involved in the activation of neo-enhancers in prostate cancer.
Valdés-Mora F; Gould CM; Colino-Sanguino Y; Qu W; Song JZ; Taylor KM; Buske FA; Statham AL; Nair SS; Armstrong NJ; Kench JG; Lee KML; Horvath LG; Qiu M; Ilinykh A; Yeo-Teh NS; Gallego-Ortega D; Stirzaker C; Clark SJ
Nat Commun; 2017 Nov; 8(1):1346. PubMed ID: 29116202
[TBL] [Abstract][Full Text] [Related]
6. Androgen receptor activity at the prostate specific antigen locus: steroidal and non-steroidal mechanisms.
Jia L; Kim J; Shen H; Clark PE; Tilley WD; Coetzee GA
Mol Cancer Res; 2003 Mar; 1(5):385-92. PubMed ID: 12651911
[TBL] [Abstract][Full Text] [Related]
7. Integration of cap analysis of gene expression and chromatin immunoprecipitation analysis on array reveals genome-wide androgen receptor signaling in prostate cancer cells.
Takayama K; Tsutsumi S; Katayama S; Okayama T; Horie-Inoue K; Ikeda K; Urano T; Kawazu C; Hasegawa A; Ikeo K; Gojyobori T; Ouchi Y; Hayashizaki Y; Aburatani H; Inoue S
Oncogene; 2011 Feb; 30(5):619-30. PubMed ID: 20890304
[TBL] [Abstract][Full Text] [Related]
8. c-Myc Antagonises the Transcriptional Activity of the Androgen Receptor in Prostate Cancer Affecting Key Gene Networks.
Barfeld SJ; Urbanucci A; Itkonen HM; Fazli L; Hicks JL; Thiede B; Rennie PS; Yegnasubramanian S; DeMarzo AM; Mills IG
EBioMedicine; 2017 Apr; 18():83-93. PubMed ID: 28412251
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol, piceatannol and analogs inhibit activation of both wild-type and T877A mutant androgen receptor.
Lundqvist J; Tringali C; Oskarsson A
J Steroid Biochem Mol Biol; 2017 Nov; 174():161-168. PubMed ID: 28888979
[TBL] [Abstract][Full Text] [Related]
10. Reprogramming transcription by distinct classes of enhancers functionally defined by eRNA.
Wang D; Garcia-Bassets I; Benner C; Li W; Su X; Zhou Y; Qiu J; Liu W; Kaikkonen MU; Ohgi KA; Glass CK; Rosenfeld MG; Fu XD
Nature; 2011 May; 474(7351):390-4. PubMed ID: 21572438
[TBL] [Abstract][Full Text] [Related]
11. The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.
Yoon HG; Wong J
Mol Endocrinol; 2006 May; 20(5):1048-60. PubMed ID: 16373395
[TBL] [Abstract][Full Text] [Related]
12. Androgen receptor overexpression alters binding dynamics of the receptor to chromatin and chromatin structure.
Urbanucci A; Marttila S; Jänne OA; Visakorpi T
Prostate; 2012 Aug; 72(11):1223-32. PubMed ID: 22212979
[TBL] [Abstract][Full Text] [Related]
13. Androgen receptor-dependent PSA expression in androgen-independent prostate cancer cells does not involve androgen receptor occupancy of the PSA locus.
Jia L; Coetzee GA
Cancer Res; 2005 Sep; 65(17):8003-8. PubMed ID: 16140973
[TBL] [Abstract][Full Text] [Related]
14. An androgen response element in a far upstream enhancer region is essential for high, androgen-regulated activity of the prostate-specific antigen promoter.
Cleutjens KB; van der Korput HA; van Eekelen CC; van Rooij HC; Faber PW; Trapman J
Mol Endocrinol; 1997 Feb; 11(2):148-61. PubMed ID: 9013762
[TBL] [Abstract][Full Text] [Related]
15. Locus-wide chromatin remodeling and enhanced androgen receptor-mediated transcription in recurrent prostate tumor cells.
Jia L; Shen HC; Wantroba M; Khalid O; Liang G; Wang Q; Gentzschein E; Pinski JK; Stanczyk FZ; Jones PA; Coetzee GA
Mol Cell Biol; 2006 Oct; 26(19):7331-41. PubMed ID: 16980632
[TBL] [Abstract][Full Text] [Related]
16. Dynamic methylation of histone H3 at lysine 4 in transcriptional regulation by the androgen receptor.
Kim J; Jia L; Tilley WD; Coetzee GA
Nucleic Acids Res; 2003 Dec; 31(23):6741-7. PubMed ID: 14627807
[TBL] [Abstract][Full Text] [Related]
17. Probasin promoter assembles into a strongly positioned nucleosome that permits androgen receptor binding.
Maffey AH; Ishibashi T; He C; Wang X; White AR; Hendy SC; Nelson CC; Rennie PS; Ausió J
Mol Cell Endocrinol; 2007 Mar; 268(1-2):10-9. PubMed ID: 17316977
[TBL] [Abstract][Full Text] [Related]
18. The histone methyltransferase, NSD2, enhances androgen receptor-mediated transcription.
Kang HB; Choi Y; Lee JM; Choi KC; Kim HC; Yoo JY; Lee YH; Yoon HG
FEBS Lett; 2009 Jun; 583(12):1880-6. PubMed ID: 19481544
[TBL] [Abstract][Full Text] [Related]
19. Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity.
Jia L; Berman BP; Jariwala U; Yan X; Cogan JP; Walters A; Chen T; Buchanan G; Frenkel B; Coetzee GA
PLoS One; 2008; 3(11):e3645. PubMed ID: 18997859
[TBL] [Abstract][Full Text] [Related]
20. KDM1A triggers androgen-induced miRNA transcription via H3K4me2 demethylation and DNA oxidation.
Yang S; Zhang J; Zhang Y; Wan X; Zhang C; Huang X; Huang W; Pu H; Pei C; Wu H; Huang Y; Huang S; Li Y
Prostate; 2015 Jun; 75(9):936-46. PubMed ID: 25728837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
